🎉 M&A multiples are live!
Check it out!

Public Comps and Valuation Multiples
for HealthTech

Benchmark revenue and EBITDA valuation multiples for public comps like Johnson & Johnson, UnitedHealth Group, Philips, Abbott Laboratories and Siemens.

HealthTech

See analyst estimates and all valuation multiples for HealthTech
Company EV EV/Revenue EV/EBITDA
$387B 4.3x 11.9x
$321B 0.8x 9.0x
$239B 5.5x 21.3x
$225B 2.6x 14.2x
$167B 9.3x 31.0x
$161B 6.8x 24.4x
$150B 6.2x 19.8x
$126B 3.7x 13.0x
$33.5B 7.8x 27.7x
$28.2B 1.4x 8.9x
$27.0B 2.0x 11.9x
$26.0B 6.7x 20.9x
$25.1B 6.0x 18.8x
$16.1B 4.0x 13.3x
$11.3B 7.3x 28.1x
$11.0B 0.3x 5.6x
$10.4B 3.0x 11.8x
$10.2B 8.1x 55.1x
$7.2B 9.5x 35.6x
$5.8B 2.4x 13.7x
$5.6B n/a n/a
$4.9B 5.6x 23.3x
$4.7B 1.4x 7.7x
$4.1B 4.6x 23.5x
$3.8B 1.4x 9.1x
$3.6B 1.4x 11.2x
$2.5B 2.8x 14.0x
$2.3B 3.9x -15.6x
$1.6B 0.2x 5.7x
$1.4B 0.4x 3.8x
$1.4B 3.2x 25.9x
$1.3B 18.2x 35.0x
$1.2B 2.2x 17.6x
$1.0B 1.1x 26.1x
$901M 2.2x 11.6x
$779M 6.3x 50.1x
$745M 2.1x 25.3x
$694M n/a n/a
$548M 1.1x 4.2x
$546M 3.8x 8.5x
$504M n/a n/a
$485M 10.2x -18.2x
$374M 120.3x -10.6x
$372M 13.3x n/a
$364M 160.2x -23.7x
$335M 1.4x 4.6x
$326M n/a n/a
$296M 0.7x 10.5x
$273M 516.2x -6.4x
$238M 0.4x 3.0x
$224M 0.8x 2.2x
$212M 0.7x 4.6x
$154M 2.5x 11.7x
$153M 1.1x 5.7x
$150M n/a n/a
$131M n/a n/a
$121M 1.0x 32.1x
$121M 2.3x -2.6x
$108M 2.3x 9.1x
$104M 2.0x 36.8x
$102M 0.5x 5.8x
$98.1M 815.7x n/a
$94.5M 20.5x -4.7x
$93.6M 2.4x -20.6x
$93.0M 34.3x -1.2x
$86.1M 11.6x n/a
$83.0M 1.4x -3.8x
$82.5M n/a n/a
$82.0M 0.7x 3.3x
$77.8M 3.4x -19.0x
$76.8M n/a n/a
$70.1M 2.7x 42.6x
$54.9M n/a n/a
$54.7M n/a n/a
$51.4M 2.8x -191.4x
$51.0M n/a n/a
$43.0M 1.9x -41.3x
$40.7M 0.7x -21.7x
$40.7M n/a n/a
$40.6M n/a n/a
$33.9M 1.2x -1.3x
$29.6M 0.6x -106.1x
$28.4M 2.9x -3.4x
$26.4M n/a n/a
$24.8M 3.5x -2.8x
$16.8M n/a n/a
$15.5M n/a n/a
$12.0M n/a n/a
$10.6M n/a n/a
$2.4M n/a n/a
-$10.9M -4.4x n/a
-$17.1M -13.9x 0.2x

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.